No cutting. No scarring.
No downtime. 95%+ effective.
Non-melanoma skin cancer patients who are seeking an alternative treatment option to Squamous cell carcinoma or Basal cell cancer Mohs surgery may be interested to learn more about IG-SRT (Image Guided Superficial Radiotherapy). What is IG-SRT? A leading-edge non-invasive treatment option for non-melanoma skin cancer that uses no cutting, leaves no scarring, and has a 95% cure rate. Although IG-SRT technology is non-invasive, patients may understandably still have some concerns before proceeding. GentleCure aims to ease some of the anxiety you may feel by providing an in-depth look at how the IG-SRT treatment process works, below.
What is the IG-SRT definition? Unlike traditional radiation that delivers massive amounts of energy that penetrates deep into the body and can cause severe skin reactions, IG-SRT technology utilizes a small, portable device that delivers very low energy just below the surface of the skin. It treats only non-melanoma skin cancers and keloids. Because IG-SRT uses low energy radiotherapy, skin reactions are typically mild and very small.
The energies of the machine used to treat Basal cell and Squamous cell carcinoma skin cancers are less than what is required for a chest X-Ray.
Local control rates for non-melanoma skin cancers including Basal cell and Squamous cell carcinomas are comparable with Mohs surgery.
IG-SRT has the added value of better cosmetic outcomes, no requirement for halting blood thinners, better outcomes for lower extremities, and little disruption in daily activities
If you have recently been diagnosed with non-melanoma skin cancer following a skin cancer screening and are wondering how to treat Squamous cell carcinoma or Basal cell cancer, one of the first treatment options you might be recommended is surgery.
When compared to IG-SRT, Squamous cell carcinoma surgery and Basal cell cancer Mohs surgery is more invasive in several ways. Surgery requires cutting that will likely leave a scar, and the patient will need to be on antibiotics following the procedure.
Treating Squamous cell carcinoma and basal cell carcinoma with Mohs surgery has implications your physician may not have discussed with you. For example, surgery requires cutting that may be painful and will likely leave a scar. Pre-surgery, you may be told to suspend use of blood thinners, and post-surgery you’ll likely need to take antibiotics. Depending on the location of the surgery, you may need time to heal before resuming daily activities. All of these side effects may be avoided by choosing a non-surgical, less invasive option like Image-Guided Superficial Radiotherapy (IG-SRT).
Compare surgery vs. IG-SRT treatment in greater depth, below:
|Leaves Scar||Possible Hypopigmentation|
|Requires Skin Flap||No Cutting|
|Requires Antibiotics||No Antibiotics Necessary|
|Stoppage of Blood Thinners||No Stoppage of Blood Thinners|
|One Lesion At a Time||Up to 3 Lesions Can Be Treated At a Time|
|Change In Daily Activity||No Change|
Have further questions about how to treat Squamous cell carcinoma or Basal cell cancer with IG-SRT technology? Please call us at 312-987-6543 to learn more. The skin cancer information specialists at GentleCure can provide all the details you need to feel confident about making your non-melanoma skin cancer treatment decision. Need help finding a treatment center that offers IG-SRT near you? Our Find a Practice tool makes it quick and easy to find the nearest location to you.